As of 2025-09-18, the Relative Valuation of Biomarin Pharmaceutical Inc (BMRN) is 57.45 USD. This relative valuation is based on P/E multiples. With the latest stock price at 54.37 USD, the upside of Biomarin Pharmaceutical Inc based on Relative Valuation is 5.7%.
The range of the Relative Valuation is 43.20 - 64.44 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 18.2x | 17.0x |
| Forward P/E multiples | 16.8x - 22.1x | 19.5x |
| Fair Price | 43.20 - 64.44 | 57.45 |
| Upside | -20.5% - 18.5% | 5.7% |
| Date | P/E |
| 2025-09-17 | 15.88 |
| 2025-09-16 | 15.76 |
| 2025-09-15 | 15.52 |
| 2025-09-12 | 15.80 |
| 2025-09-11 | 16.33 |
| 2025-09-10 | 15.92 |
| 2025-09-09 | 16.27 |
| 2025-09-08 | 16.47 |
| 2025-09-05 | 16.88 |
| 2025-09-04 | 16.58 |
| 2025-09-03 | 17.23 |
| 2025-09-02 | 17.26 |
| 2025-08-29 | 17.02 |
| 2025-08-28 | 16.85 |
| 2025-08-27 | 17.14 |
| 2025-08-26 | 16.78 |
| 2025-08-25 | 17.09 |
| 2025-08-22 | 17.11 |
| 2025-08-21 | 16.96 |
| 2025-08-20 | 16.93 |
| 2025-08-19 | 16.74 |
| 2025-08-18 | 16.78 |
| 2025-08-15 | 16.81 |
| 2025-08-14 | 16.94 |
| 2025-08-13 | 17.03 |
| 2025-08-12 | 16.61 |
| 2025-08-11 | 16.59 |
| 2025-08-08 | 16.75 |
| 2025-08-07 | 17.37 |
| 2025-08-06 | 17.72 |
| 2025-08-05 | 18.09 |
| 2025-08-04 | 17.62 |
| 2025-08-01 | 16.99 |
| 2025-07-31 | 16.90 |
| 2025-07-30 | 17.18 |
| 2025-07-29 | 17.01 |
| 2025-07-28 | 16.99 |
| 2025-07-25 | 17.24 |
| 2025-07-24 | 17.46 |
| 2025-07-23 | 17.43 |
| 2025-07-22 | 17.30 |
| 2025-07-21 | 16.52 |
| 2025-07-18 | 16.74 |
| 2025-07-17 | 17.05 |
| 2025-07-16 | 17.06 |
| 2025-07-15 | 16.54 |
| 2025-07-14 | 17.01 |
| 2025-07-11 | 16.97 |
| 2025-07-10 | 17.18 |
| 2025-07-09 | 17.43 |